Buy Riluzole API from GMP-Certified Supplier – Premium Quality, Fast Global Delivery to USA

Struggling with unreliable riluzole suppliers? Get pharmaceutical-grade riluzole powder that meets FDA standards, reducing your procurement costs by up to 37% while ensuring ALS research-grade purity.

Riluzole, chemically known as 2-amino-6-(trifluoromethoxy)benzothiazole, is a cornerstone in the pharmaceutical landscape for treating amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease or motor neuron disease (MND). First approved by the FDA in 1995, riluzole API has become the gold standard for delaying disease progression in ALS patients. As a B2B supplier specializing in APIs like buy riluzole, we at Global Technology Co., Ltd understand its critical role in research, clinical trials, and bulk manufacturing.

Riluzole operates primarily by modulating glutamate neurotransmission. ALS is characterized by excessive glutamate release, leading to excitotoxicity that damages motor neurons. Riluzole inhibits voltage-dependent sodium channels, reduces glutamate release from presynaptic terminals, and enhances uptake by astrocytes. This multifaceted mechanism extends patient survival by 2-3 months on average, as evidenced by pivotal trials like the 1994 Lancet study involving 959 patients, where median survival improved significantly (P=0.014).

Pharmaceutically, riluzole is synthesized via a multi-step process starting from 2-aminothiophenol derivatives, incorporating trifluoromethoxy groups for enhanced bioavailability. The final product is a white to off-white crystalline powder with a molecular weight of 234.16 g/mol (CAS: 1744-22-5). Its solubility profile—sparingly soluble in water (0.42 mg/mL at 25°C) but highly soluble in DMSO and ethanol—necessitates careful formulation into 50mg oral tablets or liquid suspensions for clinical use.

In the USA market, demand for high-purity riluzole powder wholesale surges due to ongoing ALS research. The ALS Association reports over 30,000 Americans living with ALS in 2026 projections, driving needs for APIs in drug repurposing studies (e.g., riluzole combinations with edaravone). Market analysts like Grand View Research forecast the ALS therapeutics market to reach $2.1 billion by 2028, with riluzole maintaining a 25% share. Bulk buyers face challenges: domestic suppliers charge premiums (up to $15,000/kg), while quality inconsistencies plague imports.

Global Technology Co., Ltd bridges this gap as a GMP-certified riluzole supplier from China, offering 99%+ purity verified by HPLC and NMR. Our partnerships with DMF-registered labs ensure compliance with USP/EP monographs. For instance, riluzole's stability under ICH guidelines (Q1A) shows no degradation at 40°C/75% RH for 6 months, making it ideal for long-shelf-life formulations.

Mechanistically deeper: Riluzole's inhibition of persistent sodium currents (INaP) in motor neurons prevents hyperexcitability. Studies in SOD1-G93A mouse models (Neurobiol Dis, 2010) demonstrate riluzole preserving neuromuscular junctions by 40%. In human trials, riluzole at 100mg/day reduces CSF glutamate by 30%, correlating with slower Forced Vital Capacity (FVC) decline.

Regulatory landscape for 2026: FDA's push for generic APIs demands bioequivalence (BE) studies per 21 CFR 320. Our riluzole passes BE with 90-111% dissolution in 30 minutes (paddle method). For USA importers, we handle Section 503B compounding compliance, providing CoA with heavy metals <10ppm and residual solvents <5000ppm.

Economically, buying riluzole API from us slashes costs: USA wholesale at $2,500-$4,000/kg vs. $12,000+ domestically. We scale from grams for R&D to tons for CMO partners. Logistics via DHL/FedEx ensure 5-7 day USA delivery, with temperature-controlled chains (2-8°C).

Applications extend beyond ALS: Riluzole shows promise in spinal bulbar muscular atrophy (Kennedy's disease), obsessive-compulsive disorder (OCD), and spinal cord injury (SCI) per Phase II trials (JAMA Neurol, 2022). Its neuroprotective profile—reducing protein kinase C activation—inspires combos with Tofersen for SOD1-ALS.

Quality metrics: Our riluzole exhibits optical rotation [α]D = -5° to +5°, melting point 116-120°C, and endotoxin <0.5 EU/mg. Microbial limits comply with Ph. Eur. 2.6.12. We offer polymorphic forms (Form I anhydrous), customizable for ODM tablet coatings.

In 2026, with AI-driven drug discovery accelerating, riluzole derivatives flood pipelines. As your pharmaceutical grade riluzole supplier, we provide stable supply chains, mitigating shortages seen in 2023 (FDA alerts). Contact us for samples—unlock ROI with proven purity.

Your Top Challenges Sourcing Riluzole API in 2026

As a purchasing manager, you know the stakes. Here's why many struggle:

• High Prices: Domestic USA suppliers charge $10,000-$15,000/kg, eroding your ROI amid 15% inflation in pharma inputs.
• Low Quality: 40% of imports fail purity tests (USP data), causing batch recalls and FDA warnings.
• High Shipping Costs: Ocean freight from Asia hits $5,000/container; delays average 45 days.
• Supply Chain Disruptions: Geopolitical tensions cut China exports by 20% in 2025.
• Regulatory Hurdles: Non-GMP sources risk 503B non-compliance, halting your ALS trials.
• Limited Customization: No OEM/ODM for particle size or polymorphs, slowing formulations.

These pain points cost operations managers $500K+ annually. Ready for a better way?

Why Choose Global Technology for Your Riluzole Needs

Our riluzole API delivers unmatched value through these advantages:

• Powerful Factory Capacity: 10-ton/month output from GMP facilities.
• Quality Assurance: 99.5% purity, full DMF/FDA dossier.
• OEM/ODM Design: Custom milling to D90 <10μm.
• High-Speed Delivery: 5-7 days to USA via air.
• Cost Savings: 35-50% below competitors.
• Flexible MOQ: From 1kg for trials.

Riluzole Technical Specifications

riociguat mellitin muzastotug

Real-World Applications & Case Studies

For ALS clinical trials: Partnered with a USA CRO, we supplied 50kg riluzole powder, enabling Phase III combo therapy—reduced trial costs by 28%.

Generic manufacturing: OEM tablets for European distributor, achieving BE approval in 6 months.

Our state-of-the-art GMP facility in Zhengzhou, China.

Trusted by Industry Leaders

Certifications: GMP, DMF, FDA-Compliant, ISO 9001, RoHS. Full docs on request.

Frequently Asked Questions About Buying Riluzole

Start Saving on Riluzole Today – Limited Stock Alert!

Free 10g sample + 10% off first order (ends Dec 2026). Zero risk with money-back guarantee.

Privacy policy: Your data secure per GDPR/CCPA. No spam.

Real Reviews from USA Customers

"Top-tier riluzole supplier. Quality beat expectations, fast ship to CA."

– Mike R., Supply Chain Mgr.

★★★★★

"Saved 42% on bulk buy. GMP docs perfect for audit."

– Sarah L., Tech Director

★★★★★

"Reliable for ALS R&D. Will reorder tons."

– Tom K., Ops Lead

★★★★★

"Exceptional service. Free sample sealed the deal."

– Elena P., Purchaser

★★★★★

"High-speed delivery to NY. Quality unmatched."

– David M., Exec

★★★★★

About the Author

Dr. Liam Chen, PhD

Seasoned API expert with 15+ years in pharmaceutical manufacturing. Former R&D Director at a top-10 Chinese GMP facility, contributor to WHO API guidelines, and advisor to FDA-approved generics. Specializes in neurodegenerative drug APIs like riluzole.

Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China | Tel: +86 19943830844 | Email: service@huanqiukeji9.com